![Chih Kai Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chih Kai Cheng
Direktor/Vorstandsmitglied bei
CONCENTRIX CORPORATION
Vermögen: 172 541 $ am 30.06.2026
Profil
Chih Kai Cheng was the founder of Harbinger Venture Management, founded in 2000, serving as General Partner from 2011 to 2015.
Mr. Cheng is the founder of B Current Impact Investment, Inc., founded in 2014, currently serving as Chairman.
Current jobs include Director at Eureka Therapeutics, Inc., Director at Social Enterprise Insights, Director at H3 Platform, Inc., and Independent Director at Concentrix Corp.
starting in 2026.
Former jobs include Director at Envivio, Inc., Crown Bioscience, Inc., Applied Optoelectronics, Inc., Cardiva Medical, Inc., Quintic Corp., General Photonics Corp., Crown Bioscience International, Independent Director at Primax Electronics Ltd. from 2015 to 2024, SVP-Product Marketing & Manufacturing Operations at TD SYNNEX Corp., and Head-US Operations at MiTAC Holdings Corp.
Education includes graduate studies at National Chiao Tung University and undergraduate studies at National Tsing-Hua University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CONCENTRIX CORPORATION 0,01 % | 25.03.2026 | 7.701 ( 0,01 % ) | 172 541 $ | 30.06.2026 |
Aktive Positionen von Chih Kai Cheng
| Unternehmen | Position | Beginn |
|---|---|---|
| CONCENTRIX CORPORATION | Direktor/Vorstandsmitglied | 25.03.2026 |
H3 Platform, Inc.
 H3 Platform, Inc. Information Technology ServicesTechnology Services Provides cloud infrastructure solutions | Direktor/Vorstandsmitglied | - |
Social Enterprise Insights | Direktor/Vorstandsmitglied | - |
B Current Impact Investment, Inc.
 B Current Impact Investment, Inc. Investment ManagersFinance Operates as a venture capital, investment and fund management company | Gründer | 10.04.2014 |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Chih Kai Cheng
| Unternehmen | Position | Ende |
|---|---|---|
| PRIMAX ELECTRONICS LTD. | Direktor/Vorstandsmitglied | 01.01.2024 |
Harbinger Venture Management
 Harbinger Venture Management Investment ManagersFinance Harbinger Ventures invests in middle market companies located in the US. The firm focuses on technology and infrastructure sectors. It participates in early and later stage capital requirements. | Gründer | 01.12.2015 |
| APPLIED OPTOELECTRONICS, INC. | Direktor/Vorstandsmitglied | 20.02.2013 |
| MITAC HOLDINGS CORPORATION | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Chih Kai Cheng
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Primax Electronics Ltd.
 Primax Electronics Ltd. Computer PeripheralsElectronic Technology Manufactures and distributes computer peripherals and equipment | Electronic Technology |
Envivio, Inc.
 Envivio, Inc. Major TelecommunicationsCommunications Provides VOIP solutions | Communications |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization for drug discovery | Commercial Services |
Applied Optoelectronics, Inc.
 Applied Optoelectronics, Inc. SemiconductorsElectronic Technology Designs, develops and manufactures optical devices | Electronic Technology |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors | Health Technology |
TD SYNNEX Corp.
 TD SYNNEX Corp. Electronics DistributorsDistribution Services Develops and distributes computer systems and complementary products | Distribution Services |
National Chiao Tung University
 National Chiao Tung University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbinger Venture Management
Harbinger Venture Management Investment ManagersFinance Harbinger Ventures invests in middle market companies located in the US. The firm focuses on technology and infrastructure sectors. It participates in early and later stage capital requirements. | Finance |
National Tsing-Hua University
 National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiva Medical, Inc.
 Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops vascular closure for patients, hospitals and physicians | Health Technology |
Quintic Corp.
 Quintic Corp. SemiconductorsElectronic Technology Provides wireless connectivity solutions | Electronic Technology |
General Photonics Corp.
 General Photonics Corp. Electronic Production EquipmentElectronic Technology Manufactures fiber optic communication equipment and electronic components | Electronic Technology |
MiTAC Holdings Corp.
 MiTAC Holdings Corp. Computer Processing HardwareElectronic Technology Manufactures consumer electronics | Electronic Technology |
Concentrix Corp.
 Concentrix Corp. Information Technology ServicesTechnology Services Provides technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial and insurance and healthcare services | Technology Services |
Social Enterprise Insights | |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Operates as a biotechnology company that develops drug for oncology and metabolic diseases | Health Technology |
B Current Impact Investment, Inc.
B Current Impact Investment, Inc. Investment ManagersFinance Operates as a venture capital, investment and fund management company | Finance |
H3 Platform, Inc.
H3 Platform, Inc. Information Technology ServicesTechnology Services Provides cloud infrastructure solutions | Technology Services |
